rs310214

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002227.4(JAK1):​c.1649-720A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.412 in 152,054 control chromosomes in the GnomAD database, including 14,446 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 14446 hom., cov: 32)

Consequence

JAK1
NM_002227.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.174

Publications

1 publications found
Variant links:
Genes affected
JAK1 (HGNC:6190): (Janus kinase 1) This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020]
JAK1 Gene-Disease associations (from GenCC):
  • autoinflammation, immune dysregulation, and eosinophilia
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.621 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002227.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
NM_002227.4
MANE Select
c.1649-720A>G
intron
N/ANP_002218.2
JAK1
NM_001320923.2
c.1649-720A>G
intron
N/ANP_001307852.1
JAK1
NM_001321852.2
c.1649-720A>G
intron
N/ANP_001308781.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
ENST00000342505.5
TSL:5 MANE Select
c.1649-720A>G
intron
N/AENSP00000343204.4
JAK1
ENST00000671929.2
c.1649-720A>G
intron
N/AENSP00000500485.1
JAK1
ENST00000671954.2
c.1649-720A>G
intron
N/AENSP00000500841.1

Frequencies

GnomAD3 genomes
AF:
0.412
AC:
62569
AN:
151936
Hom.:
14395
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.627
Gnomad AMI
AF:
0.232
Gnomad AMR
AF:
0.451
Gnomad ASJ
AF:
0.392
Gnomad EAS
AF:
0.308
Gnomad SAS
AF:
0.291
Gnomad FIN
AF:
0.327
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.306
Gnomad OTH
AF:
0.386
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.412
AC:
62682
AN:
152054
Hom.:
14446
Cov.:
32
AF XY:
0.411
AC XY:
30564
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.628
AC:
26047
AN:
41492
American (AMR)
AF:
0.452
AC:
6900
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.392
AC:
1360
AN:
3466
East Asian (EAS)
AF:
0.308
AC:
1586
AN:
5156
South Asian (SAS)
AF:
0.292
AC:
1408
AN:
4822
European-Finnish (FIN)
AF:
0.327
AC:
3452
AN:
10562
Middle Eastern (MID)
AF:
0.262
AC:
77
AN:
294
European-Non Finnish (NFE)
AF:
0.306
AC:
20814
AN:
67966
Other (OTH)
AF:
0.392
AC:
827
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1735
3470
5205
6940
8675
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.401
Hom.:
1733
Bravo
AF:
0.432
Asia WGS
AF:
0.340
AC:
1184
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.6
DANN
Benign
0.35
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs310214; hg19: chr1-65317313; API